Learn More
Selleck Chemical LLC S-Ruxolitinib (INCB018424) S2902-1g

Supplier: Selleck Chemical LLC S29021G
S-Ruxolitinib is the chirality of INCB018424 which is the first potent selective JAK1/2 inhibitor to enter the clinic with IC50 of 3 3 nM/2 8 nM 130-fold selectivity for JAK1/2 versus JAK3 Phase 3
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.